These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. The distribution of intratumoral macrophages correlates with molecular phenotypes and impacts prognosis in colorectal carcinoma. Kim Y; Wen X; Bae JM; Kim JH; Cho NY; Kang GH Histopathology; 2018 Oct; 73(4):663-671. PubMed ID: 29906313 [TBL] [Abstract][Full Text] [Related]
43. [Prognostic significance of natural killer cell infiltration in hepatocellular carcinoma]. Zhu LY; Zhou J; Liu YZ; Pan WD Ai Zheng; 2009 Nov; 28(11):1198-202. PubMed ID: 19895742 [TBL] [Abstract][Full Text] [Related]
44. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3. Scott AA; Head DR; Kopecky KJ; Appelbaum FR; Theil KS; Grever MR; Chen IM; Whittaker MH; Griffith BB; Licht JD Blood; 1994 Jul; 84(1):244-55. PubMed ID: 7517211 [TBL] [Abstract][Full Text] [Related]
45. Mass Cytometry Reveals a Sustained Reduction in CD16 Shinko D; McGuire HM; Diakos CI; Pavlakis N; Clarke SJ; Byrne SN; Charles KA Front Immunol; 2019; 10():2584. PubMed ID: 31749810 [TBL] [Abstract][Full Text] [Related]
46. Baseline Peripheral Blood Leukocytosis Is Negatively Correlated With T-Cell Infiltration Predicting Worse Outcome in Colorectal Cancers. Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai SJ Front Immunol; 2018; 9():2354. PubMed ID: 30369930 [TBL] [Abstract][Full Text] [Related]
47. Proliferating endothelial cells and leukocyte infiltration as prognostic markers in colorectal cancer. Baeten CI; Castermans K; Hillen HF; Griffioen AW Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1351-7. PubMed ID: 17059898 [TBL] [Abstract][Full Text] [Related]
50. [Predictive value of intraepithelial (CD3) T-lymphocyte infiltration in resected colorectal cancer]. Borda F; Martínez-Peñuela JM; Borda A; Muñoz-Navas M; Jiménez J; Carretero C Gastroenterol Hepatol; 2012 Oct; 35(8):541-50. PubMed ID: 22858112 [TBL] [Abstract][Full Text] [Related]
51. The presence of CD56/CD16 in T-cell acute lymphoblastic leukaemia correlates with the expression of cytotoxic molecules and is associated with worse response to treatment. Dalmazzo LF; Jácomo RH; Marinato AF; Figueiredo-Pontes LL; Cunha RL; Garcia AB; Rego EM; Falcão RP Br J Haematol; 2009 Jan; 144(2):223-9. PubMed ID: 19016721 [TBL] [Abstract][Full Text] [Related]
52. High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients. Frey DM; Droeser RA; Viehl CT; Zlobec I; Lugli A; Zingg U; Oertli D; Kettelhack C; Terracciano L; Tornillo L Int J Cancer; 2010 Jun; 126(11):2635-43. PubMed ID: 19856313 [TBL] [Abstract][Full Text] [Related]
53. Distinguishing human peripheral blood CD16 Fromm PD; Silveira PA; Hsu JL; Papadimitrious MS; Lo TH; Ju X; Kupresanin F; Romano A; Hsu WH; Bryant CE; Kong B; Abadir E; Mekkawy A; M McGuire H; Groth BFS; Cunningham I; Newman E; Gibson J; Hogarth PM; Hart DNJ; Clark GJ J Leukoc Biol; 2020 Feb; 107(2):323-339. PubMed ID: 31749181 [TBL] [Abstract][Full Text] [Related]
54. The Role of Circulating CD16+CD56+ Natural Killer Cells in the Screening, Diagnosis, and Staging of Colorectal Cancer before Initial Treatment. Cui F; Qu D; Sun R; Tao H; Si J; Xu Y Dis Markers; 2019; 2019():7152183. PubMed ID: 31636738 [TBL] [Abstract][Full Text] [Related]
55. Identification and characterization of a tumor infiltrating CD56(+)/CD16 (-) NK cell subset with specificity for pancreatic and prostate cancer cell lines. Frankel TL; Burns W; Riley J; Morgan RA; Davis JL; Hanada K; Quezado M; Rosenberg SA; Royal RE Cancer Immunol Immunother; 2010 Dec; 59(12):1757-69. PubMed ID: 20734041 [TBL] [Abstract][Full Text] [Related]
56. Mismatch repair gene defects in sporadic colorectal cancer enhance immune surveillance. Scarpa M; Ruffolo C; Canal F; Scarpa M; Basato S; Erroi F; Fiorot A; Dall'Agnese L; Pozza A; Porzionato A; Castagliuolo I; Dei Tos AP; Bassi N; Castoro C Oncotarget; 2015 Dec; 6(41):43472-82. PubMed ID: 26496037 [TBL] [Abstract][Full Text] [Related]
57. Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer. Kuwahara T; Hazama S; Suzuki N; Yoshida S; Tomochika S; Nakagami Y; Matsui H; Shindo Y; Kanekiyo S; Tokumitsu Y; Iida M; Tsunedomi R; Takeda S; Yoshino S; Okayama N; Suehiro Y; Yamasaki T; Fujita T; Kawakami Y; Ueno T; Nagano H Br J Cancer; 2019 Oct; 121(8):659-665. PubMed ID: 31488881 [TBL] [Abstract][Full Text] [Related]
58. The clinical utility of the local inflammatory response in colorectal cancer. Richards CH; Roxburgh CS; Powell AG; Foulis AK; Horgan PG; McMillan DC Eur J Cancer; 2014 Jan; 50(2):309-19. PubMed ID: 24103145 [TBL] [Abstract][Full Text] [Related]
60. Image analyzer-based assessment of tumor-infiltrating T cell subsets and their prognostic values in colorectal carcinomas. Kim Y; Bae JM; Li G; Cho NY; Kang GH PLoS One; 2015; 10(4):e0122183. PubMed ID: 25875774 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]